The Global NITAG Network (GNN) is a global platform that helps foster collaborations, sharing of experiences and knowledge exchange among NITAGs across all regions. The GNN monthly updates include the latest recommendations issued by NITAGs as well as policy guidance from SAGE.

GNN monthly update: January 23

Dear all,   Compliments of the season! Here is the first update of 2023. Reminder: If you would like to advertise the work of your NITAG through these monthly update, you can contact me with your recommendation.If your NITAG would like to become a GNN member, please send me an email with the contact details of the chair and the secretariat.If ...
Continue reading
  5 Hits
  0 Comments

GNN monthly update: December 22'

Dear all,   This is the last update of 2022!   COVID-19: Booster dose: French NITAG has preferentially recommended bivalent vaccines suitable for Omicron, regardless of the vaccine(s) previously administered. The full recommendation on booster vaccine strategy is available here. The French NITAG recommends integrating the Nuvaxovid vaccin...
Continue reading
  27 Hits
  0 Comments

GNN monthly update: November 22'

Dear all,   The end of this year is fast approaching and the monthly updates 22’ will also pause during the December break. In November, our article based on the survey conducted through the GNN on COVID-19 vaccine policy development was finally published and is accessible in open access here: https://www.sciencedirect.com/science/article/pii/...
Continue reading
  72 Hits
  0 Comments

GNN monthly update: October 22

Dear all,   Here is the October update and this month is ending with the GNN webinar. We discussed the recent SAGE recommendations on monkeypox and COVID-19 variant-containing vaccines as well as the access and programmatic implications for future COVID-19 vaccination. The meeting presentations will be circulated separately but the recording i...
Continue reading
  93 Hits
  0 Comments

GNN monthly update: September 22

Dear all,   Here comes the end of September, the fall season and the second ordinary SAGE meeting! NITAGs are getting back to other topics than COVID-19 vaccines and COVID-19 working groups are meeting less often - this will hopefully allow NITAG members to tackle the decrease in childhood immunization coverage and the ambitious IA2030 objecti...
Continue reading
  129 Hits
  0 Comments

GNN monthly update: August' 22

Dear all,   I hope everyone enjoyed a break over the summer/winter depending on where you are in the world.   COVID-19 vaccines Novavax: On July 19, 2022, the ACIP made an interim recommendation for use of the Novavax vaccine in persons aged ≥18 years as a primary 2-dose series vaccination for the prevention of COVID-19, available here al...
Continue reading
  201 Hits
  0 Comments

GNN monthly update: July' 22

Subject: GNN monthly update July' 22   Dear all,   This month ends with two great meetings where some of you were able to meet face-to-face and it is always a pleasure to see the NITAG community so vibrant. 3 main points from this monthly update: a SAGE extraordinary meeting is being held on August 11th to discuss Valneva vaccine, second ...
Continue reading
  170 Hits
  0 Comments

GNN monthly update: June' 22

Dear all,   Here comes the June update focusing mostly on COVID-19 vaccines and Monkeypox outbreak response.   NITAG publications and updates:   COVID-19 additional Booster doses: ATAGI (Australia) recommends a first booster dose for adolescents (12-15 years old) who are severely immunocompromised, who have a disability with signific...
Continue reading
  234 Hits
  0 Comments

GNN monthly update: May' 22

GNN monthly update: May' 22
NITAG publications and updates:   COVID-19 additional Booster doses: CDC provided clinical considerations for a Second COVID-19 Vaccine Booster Dose, summarized in a one pager here.NACI released initial guidance on a second booster dose of COVID-19 vaccines in Canada, urging jurisdictions to prepare for the rapid deployment...
Continue reading
  318 Hits
  0 Comments

GNN webinar and NACI's message

GNN webinar and NACI's message
Dear all,   Please find attached the agenda for the GNN webinar of May 2nd at 2pm. We hope to see you there.   NACI would also like to share with the NITAG community the following information that may be of interest to you:   We are from the Public Health Agency of Canada (PHAC) writing to you about our recent public consultation on ...
Continue reading
  288 Hits
  0 Comments

GNN monthly update: April' 22

GNN monthly update: April' 22
NITAG publications and updates:   COVID-19 Booster vaccination: NACI updated its guidance on a first booster dose of COVID-19 vaccines in Canada. In particular: NACI has strengthened the following recommendations from ‘may’ to ‘should,’ so that now all adults 18 years of age and over are strongly recommended to receive a booster dose: A first ...
Continue reading
  326 Hits
  0 Comments

GNN monthly update: March' 22

GNN monthly update: March' 22
NITAG publications and updates:   COVIFENZ: NACI recommends the Medicago Covifenz COVID-19 vaccine for use as a primary series in people 18 to 64 years of age. This is the first plantbased virus-like particle (VLP) vaccine authorized for use in Canada. Clinical trials show the Medicago Covifenz COVID-19 vaccine has a good safety profile and is...
Continue reading
  292 Hits
  0 Comments

GNN monthly update: February' 22

GNN monthly update: February' 22
Dear all, Please find below the GNN monthly update for February’ 22:   NITAG publications and updates:   COVID-19 booster Doses: ATAGI (Australia) recommends the use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years. The statement is available here. Of note, Pfizer vaccine is the only brand currently registered ...
Continue reading
  325 Hits
  0 Comments

GNN monthly update: January' 22

Dear all, Best wishes to all of you for this new year! The year started with a first extraordinary SAGE meeting on January 19th which focused on major revision to the WHO SAGE Roadmap for Prioritizing Use of COVID-19 Vaccines. While the previous version of the Roadmap was developed in the context of  vaccine supply constraints, this updated ve...
Continue reading
  333 Hits
  0 Comments

GNN monthly update: December' 21

Please find below the GNN monthly update for December’ 21:   NITAG publications and updates:   COVID-19 additional and booster Doses: NACI (Canada) has updated its booster recommendations.NACI strongly recommends a booster dose of an authorized mRNA COVID-19 vaccine should be offered at least 6 months after completion of a primary COVID19...
Continue reading
  410 Hits
  0 Comments

GNN webinar Dec 15th 2021 - presentations

Dear all, Thank you all who could participate in the GNN webinar yesterday. It has been very fruitful to hear current situations on booster vaccination and timing for the booster dose as well as challenges on product specific vaccines. We also hope that you will make the most of the Sysvac registry. All the presentations are available here. The rec...
Continue reading
  351 Hits
  0 Comments

GNN Monthly Update: November 2021

Please find below the GNN monthly update for November 21: NITAG publications and updates:   COVID-19 additional and booster Doses: NACI (Canada) strongly recommends that populations at highest risk of waning protection following their primary series and at highest risk of severe COVID-19 illness should be offered a booster dose of an mRNA COVI...
Continue reading
  419 Hits
  0 Comments

GNN September 2021 update

Please find below the GNN monthly update for September’ 21:   NITAG publications and updates:   COVID-19 booster Dose: JCVI (UK) has issued updated advice on COVID-19 booster vaccination.The Belgian NITAG recommends an additional dose of mRNA COVID-19 vaccine for older adults (age cut-off: 65 years). The advice is available in French here...
Continue reading
  394 Hits
  0 Comments

GNN October 2021 update

 NITAG publications and updates: COVID-19 extended primary series: HAS (France) has issued updated advice on booster vaccination with COMIRNATY mRNA vaccine. The NITAG recommends a booster dose for people aged 65+, health care workers and people living in close contact with an immunocompromised person. Norwegian National Institute of Public He...
Continue reading
  405 Hits
  0 Comments